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ABSTRACT
Polyamines are a class of essential nutrients involved in many basic cellular processes such as
gene expression, cell proliferation, and apoptosis. Without polyamines, cell growth is delayed or
halted. Cancerous cells require an abundance of polyamines through a combination of synthesis
and transport from the extracellular environment.
An FDA-approved drug, D,L-αdifluoromethylornithine (DFMO), blocks polyamine synthesis but is ineffective at inhibiting cell
growth due to polyamine transport. Thus, there is a need to develop drugs that inhibit polyamine
transport to use in combination with DFMO. Surprisingly, little is known about the polyamine
transport system in humans and other eukaryotes. Understanding the transport system would allow
us to identify compounds that inhibit polyamine transport, which could then be used in tandem
with DFMO to treat cancer. Our laboratory has identified one gene in Drosophila, called
CG32000, as a component of this transport system, and numerous other candidate genes remain to
be tested.
To better characterize this system, this project investigated the ability of the Drosophila
transport system to take up a toxic polyamine analogue called norspermidine, with the initial goal
of developing a new screening method to find polyamine transport genes. My experiments have
demonstrated significant differences in norspermidine uptake and toxicity between C. elegans and
Drosophila which may imply a secondary polyamine transport system in higher eukaryotes. In the
long term, it is hoped that this thesis will facilitate the development of more effective cancer
medications by providing new information about the polyamine transport system.
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INTRODUCTION

Physiological Roles of Polyamines:

Polyamines are a class of crucial nutrients that are involved in many cell processes such as gene
expression and cell growth and cell death (Childs, 2003). Common polyamines include putrescine,
spermine, and spermidine. In mammals, spermine and spermidine are present in much higher
levels than putrescine, from which they are synthesized (Pegg, 2009). At physiological pH,
polyamines are polycationic and therefore able to interact with negatively charged regions of
macromolecules such as DNA and RNA. Because of these interactions, polyamines have been
implicated in the synthesis, stability, and transcription of DNA, as well as ion channel regulation
and phosphorylation of proteins (Hochman, 1978; Tabib, 1994; Panagiotidis, 1995; Childs, 2003).
On a broader level, studies suggest that polyamines play a role in longevity and stress response
(Eisenberg, 2009; Rhee, 2007; Minois, 2011). Polyamines are present in all cells and levels of
polyamines are carefully regulated, indicating their universal importance (Russell, 1983).
Regulation of polyamine levels is accomplished through synthesis, transport, and catabolism.
Regulation of Polyamine Levels:

The polyamine synthesis pathway begins with arginine and methionine (Figure 1). Arginase
converts arginine to ornithine, which is then converted to putrescine by ornithine decarboxylase
(ODC) (Hochman, 1978; Tabib, 1994; Panagiotidis, 1995; Childs, 2003). Methionine is converted
to S-adenosyl-L-methionine, decarboxylated, and then added to putrescine to produce spermidine
or to spermidine to produce spermine. The pathway can also be reversed to produce putrescine
1

from spermine or spermidine. The conversion of ornithine to putrescine by ODC is a crucial step
in this pathway. Transcription of the ODC gene is tightly regulated and the ODC protein is posttranslationally regulated. The ODC antizyme inhibits ODC and facilitates its degradation (Minois,
2011). These mechanisms ensure that cells maintain proper levels of polyamines.

Figure 1: Regulation of cellular polyamine levels. Cells maintain the necessary levels of polyamines through
synthesis from arginine and S-adenosylmethionine and through polyamine transport. (Soda, 2011).
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Polyamines and Disease:

Polyamine metabolism is important in several human pathologies. Leishmaniasis is a neglected
tropical disease caused by the Leishmania parasite, and an estimated 2 million cases occur
annually, often resulting in lasting disability (Desjeux, 2001). Levels of putrescine, spermidine,
and spermine fluctuate during the cell cycle of the Leishmania parasite and peak during
logarithmic growth, indicating the importance of polyamines in their development (Bachrach,
1979). The malarial parasite also depends on high levels of polyamine biosynthesis for
development and synthesis of proteins and amino acids, because its human erythrocyte host cells
lack the enzymes needed to synthesize polyamines (Assaraf, 1984). The protozoan T. cruzi is the
causative agent for Chagas’ disease, a neglected tropical disease that affects 8 million people
worldwide and for which few effective drug treatments are available (Bern, 2011). Unlike other
protozoans, T. cruzi depends solely on polyamine transport to obtain polyamines and will die if its
supply is lost, making the polyamine transport system in T. cruzi a promising target for new drugs
(Reigada, 2017). Multi-drug resistant Mycobacterium tuberculosis is yet another emerging world
health concern, and a 2013 study suggests that polyamines may be a contributing factor (Sarathy,
2013). Beyond pathogenic diseases, polyamines have been linked to inflammatory diseases, liver
disease, stroke, Alzheimer and Huntington’s disease (Hussain, 2017; Minois, 2011).
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Polyamines and Cancer:

Polyamines play a significant role in cancer. Because of their high rate of growth, cancer cells
require high levels of polyamines (Luk, 1987). This is reflected by increased levels of blood and
urine polyamines in cancer patients. Blood and urine polyamine levels return to normal levels
once the cancer has been completely eradicated (Loser, 1990; Chatel, 1987; Kubota, 1985; Uehara,
1980). It has further been noted that higher polyamine levels in the blood and urine correspond
with more severe prognoses (Durie, 1977). An increased capacity to synthesize polyamines
correlates with increased production of proteinases to degrade tissues around a tumor resulting in
higher levels of extracellular polyamines. Immune cells in the high polyamine environment of the
tumor show reduced anti-tumor function which may be related to high levels of polyamines (Soda,
2011). Thus, blocking the supply of polyamines to cancer cells presents a promising therapeutic
strategy.
An existing polyamine synthesis-blocking, FDA-approved drug called difluoromethylornithine
(DFMO) has shown promise in treating cancer, especially pancreatic cancer (Mohammed, 2014).
This is noteworthy because pancreatic cancer was the third leading cause of cancer deaths in the
United States in 2016 (Siegel, 2016). Pancreatic cancer is especially dangerous because physical
symptoms – such as weight loss and fatigue – are not specific to the disease, which complicates
diagnosis and delays treatment. When the cancer is finally diagnosed, few effective treatments are
available.
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Polyamine Transport:

While DFMO is a promising treatment option, it is limited as a chemotherapeutic agent because
malignant cells are also able to transport polyamines from their environment. The polyamine
transport system (PTS) is understood in E.coli (Kashiwagi, 1995), yeast (Uemura, 2005), and some
unicellular protozoans (Marie-Pierre, 2005; Machius, 2007). In these organisms, polyamine
transport is controlled by a complex of proteins: for example, in E. coli the proteins potB and -C
form a channel while potA and -D coordinate with them to control spermidine uptake (Kashiwagi,
1995). However, only a few scattered components of the polyamine transport system in
multicellular animals have been identified (Belting, 2003; Uemura, 2008; Heinick, 2010; Hiasa,
2014), and the overall mechanism is not yet understood. Currently, there are three principle
proposed models of polyamine transport, as discussed in a review by Poulin et al (Poulin, 2012):
glypican-1-dependent endocytosis (Belting, 2003), caveolin-mediated endocytosis utilizing an
unidentified receptor (Uemura, 2010), and entry via an energy-dependent channel or transporter
followed by packaging into endosomes for storage (Soulet, 2004). The three models are not
necessarily mutually exclusive, and polyamine transport may occur via combinations of these
models. Therefore, elucidating the polyamine transport system in eukaryotes would facilitate the
development of a transport inhibitor to be used in conjunction with DFMO.
As part of our effort to understand the PTS in Drosophila, our laboratory has identified a gene,
CG32000, that is required for polyamine transport and which has a human orthologue, ATP13A3.
CG32000 encodes a type P5B-ATPase, a subfamily of proteins whose function was previously
unknown. CG32000 encodes multiple proteins via alternative splicing and therefore may encode
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a family of polyamine transporters. A closely related P5A-ATPase encoded by CG6320 was not
found to play a role in transport, indicating a high level of specificity and providing a useful
control. Based on the complexes observed in E. coli and yeast, polyamine transport in higher
organisms is also likely to involve a complex of proteins and therefore it is important to identify
additional genes required for polyamine transport. Additionally, as our laboratory continues to
investigate the role of CG32000, identifying its partners will facilitate our understanding.
The DFMO Assay:

Previous studies have indicated that the polyamine transport system in Drosophila is highly
comparable to that of vertebrates, making Drosophila a good model for understanding the PTS
(Tsen, 2008; Wang et al 2017). Our laboratory currently uses a DFMO based assay for screening
candidate genes which involves knocking out the gene of interest in Drosophila using RNAi. To
achieve this, fly strains are engineered so that one strain expresses the GAL4 transcription factor,
a protein found originally in yeast, linked to a ubiquitously expressed promoter such as that for
actin (Figure 2). This strain is crossed with another strain that contains an upstream activating
sequence (UAS) that binds GAL4 upstream of a sequence that will produce double stranded RNA
(dsRNA) complimentary to the gene of interest. When the GAL4 and the UAS sequences are
present in the same animal, Gal4 activates transcription of the dsRNA, which is processed by Dicer
and used to degrade RNA transcribed from the gene of interest. In this way, the functions of genes
that may be otherwise lethal can be tested without maintaining a stock of mutant animals (Duffy,
2002). Once flies with the desired gene knockout have been bred, the offspring larvae are grown
in the presence of DFMO and polyamines. DFMO disables their ability to synthesize polyamines,
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forcing them to transport to survive. Because polyamines are added to the fly media, animals with
a functional transport system can transport polyamines and survive in the presence of DFMO. If a
crucial transport gene has been knocked out, the animals will be unable to transport and will die.

Figure 2: GAL4/UAS system in Drosophila. Flies expressing the GAL4 transcription factor are crossed with flies
expressing an Upstream Activating Sequence (UAS) that binds GAL4 to allow transcription of the desired gene or
dsRNA for RNAi. (Caldwell, 2013).

While the DFMO assay is useful, it has several limitations. Genes must be tested individually, and
several treatment conditions must be set up for each gene because of the various controls used.
Because the majority of the larvae will survive and must be counted at least daily over the course
of 2-3 weeks, tracking the results of the assay is similarly labor-intensive.
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An Alternative Approach:

Norspermidine, a toxic polyamine, presented a promising alternative screening method.
Norspermidine is an analog of spermidine, differing by only one carbon atom. In C. elegans, it
was used in an assay to find the polyamine transport gene CATP-5, an ortholog of Drosophila
CG32000 (Heinick, 2010). In an assay similar to the DFMO assay described above, nematodes
were exposed to norspermidine, and worms with a functional transport system did not survive.
Mutants with a nonfunctional transport system, however, were able to survive when grown in the
presence of lethal levels of norspermidine. The work demonstrated that CATP-5 was necessary
for norspermidine uptake. As this discovery led to the identification of CG32000 as a polyamine
transport system component in Drosophila, a norspermidine assay appeared to be a promising
approach to identifying additional components. If a norspermidine assay could be replicated in
Drosophila, it would only require two treatment conditions to test a gene (the lethal concentration
of norspermidine and the control), and vials could be rapidly checked for survivors that would
indicate a positive result. Additionally, multiple fly strains with different gene knockdowns could
be tested in the same vials and either eliminated together or tested individually if survivors were
observed. All other advantages aside, a norspermidine assay could simply provide a second line of
evidence to confirm results from the DFMO assay.
In this study, I investigated the effect of norspermidine on Drosophila lines with functional and
nonfunctional transport systems and determined the feasibility of developing a norspermidine
assay in Drosophila to screen for genes associated with the polyamine transport system.
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METHODS
Determining the lethal dose of norspermidine for Drosophila:

To investigate whether disrupting CG32000 conferred norspermidine resistance, the lethal
concentration of norspermidine for wild-type OreR flies was first identified to provide a point of
comparison.
200 female OreR flies and 50 males were allowed to breed and lay their eggs on an agar plate
containing grape juice, which provided an ideal environment for larval growth and subsequent
collection. The following protocol was used to produce these grape plates: 376 mL ddH2O and
126 mL grape juice were added to a 2 L flask along with a magnetic stir rod. The mixture was
stirred until homogenous and 15 g agar and 6 g sucrose were then added. The flask was covered
with aluminum foil and heated at 450 degrees C until boiling occurred, after which it was removed
from the hot plate for 5 minutes. The flask was then placed again on the hot plate and stirred until
the contents reached 60 degrees C. 10 mL of 100% ethanol and 5 mL glacial acetic acid were
added, and the flask was stirred for an additional 3 minutes. The mixture was poured into Petri
dishes and left overnight to set before being stored at 4 degrees C until used.
A small amount of yeast paste (made from instant yeast and water) was applied to each grape plate
to provide food for the adult flies. Grape plates were replaced regularly to ensure that sufficient
numbers of eggs would be obtained and cleared of larvae and yeast paste 4 hours before collection
so that larvae would emerge synchronously. Larvae were collected at the first instar stage and
placed into vials containing jazz mix medium (a standard fly food containing yeast, agar, cornmeal,
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and sugar) obtained from Fisher Scientific and varying concentrations of norspermidine, with 50
larvae per vial.
Vials were prepared as follows:
226.8 𝑔 𝑗𝑎𝑧𝑧 𝑚𝑖𝑥
1050 𝑚𝐿 𝑡𝑜𝑡𝑎𝑙 𝑓𝑜𝑜𝑑

1200 𝑚𝐿 𝐻2𝑂
1050 𝑚𝐿 𝑡𝑜𝑡𝑎𝑙 𝑓𝑜𝑜𝑑

× (# 𝑜𝑓 𝑣𝑖𝑎𝑙𝑠) × 6.0 𝑚𝐿 𝑓𝑜𝑜𝑑 𝑝𝑒𝑟 𝑣𝑖𝑎𝑙 = 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑗𝑎𝑧𝑧 𝑚𝑖𝑥 𝑛𝑒𝑒𝑑𝑒𝑑

× (# 𝑜𝑓 𝑣𝑖𝑎𝑙𝑠) × 5.4 𝑚𝐿 𝑓𝑜𝑜𝑑 𝑝𝑒𝑟 𝑣𝑖𝑎𝑙 = 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 𝑛𝑒𝑒𝑑𝑒𝑑

Jazz mix and water were combined in a 500 mL Erlenmeyer flask along with a magnetic stir rod,
covered with aluminum foil, and heated at 415 degrees C until boiling. The temperature was then
reduced to 225 degrees C for 10 minutes before being pipetted into vials, with 5.4 mL per vial.
Vials were then placed in a 55-degree C water bath for 10 minutes. 98% norspermidine (obtained
from Sigma-Aldrich and stored at 20 degrees C) was then added in the appropriate concentrations
and each vial was mixed thoroughly. Vials were allowed to cool at room temperature for at least
30 minutes and any condensation was removed before larvae were added.
Strains used in norspermidine sensitivity experiments:

OreR: This strain is considered to be wild-type.
CG6230: CG6230 encodes a highly similar protein to CG32000 that is not transport-related. RNAi,
together with the Gal4 system, was used to produce a ubiquitous targeted gene knockdown.
CG32000 B exon: This strain has a 2 kilobase mobile element insertion in the B exon of CG32000.
To verify that the insertion disrupted CG32000 activity and prevented polyamine transport, larvae
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were exposed to DFMO and polyamines in the following combinations and concentrations (Table
1):
Table 1: Drug concentrations for DFMO assay.

Contents:

Treatment

Treatment

Treatment

Treatment

Treatment

Treatment

1

2

3

4

5

6

ddH2O

5 Mm

0.4 mM

0.4 mM

0.2 mM

0.2 mM

DFMO

Putrescine

Putrescine

Spermidine Spermidine

5 mM

5 mM

DFMO

DFMO

CG32000 RNAi: A strain expressing RNAi against CG32000 was also tested. The experimental
design was the same as for the CG32000 B exon.
Determination of Developmental Profiles:

OreR larvae were exposed to 0, 5, 10, 15, 20, 25, and 30 mM norspermidine and adult flies were
counted daily to determine the wild-type developmental profile under each condition. B exon
larvae were then exposed to the same concentration and their developmental profile was similarly
observed.
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RESULTS
Determination of a Lethal Concentration of Norspermidine to Drosophila:

In C. elegans the lethal concentration of norspermidine is 3 mM (Heinick, 2010). I therefore grew
wild-type Drosophila OreR strain larvae in media containing 0, 1, 2, 3, 4, and 5 mM
norspermidine. Survival rates at these concentrations of norspermidine are shown in Figure 3.
Surprisingly, statistical analysis (1-way ANOVA) revealed no differences in larval survival within

Percent Surivival, normalized to control

this range of concentrations with 100 percent viability observed in each case.

140
120
100
80
60
40
20
0
0

1

2

3

4

5

Concentration of Norspermidine (mM)

Figure 3:Percent survival of OreR larvae in 0-5 mM norspermidine. Each concentration was tested in triplicate.
Error bars reflect standard error. Data were normalized with the 0 mM control set as 100%.

Based on these results I tested norspermidine at higher concentrations up to 30mM (Figure 4).
Statistical analysis (1-way ANOVA) revealed significantly reduced viability compared to the 0
12

mM control at concentrations around 10 mM and higher. Complete lethality was observed at 30
mM.

120

Percent Survival

100

***

80
60

***

40

***

***

20
0
0

5

10

15

20

25

30

Concentration of Norspermidine (mM)

Figure 4:Percent survival of OreR larvae in 0-30 mM norspermidine. All concentrations were tested in triplicate.
Error bars reflect standard error. Data were normalized with the 0 mM control set as 100%. P<0.001 for all
concentrations above 5 mM.

Knockdown of the Polyamine Transport Gene CG32000 Does Not Prevent Uptake of
Norspermidine.

Having established a lethal concentration of norspermidine I next asked if norspermidine utilizes
the PTS to gain entry into cells. To test this hypothesis, I asked if norspermidine uptake was
inhibited by RNAi knockdown or mutation of CG32000. Our laboratory has shown that RNAi
against CG32000 blocks polyamine transport (Barnett and von Kalm; unpublished). The CG32000
mutation tested is a mobile element (Piggy Bac) insertion in the 5’UTR of the B exon, and in
13

homozygous condition this mutation also blocks polyamine transport. As controls I also tested
strain OreR and RNAi against CG6230 which encodes a related P type-5A ATPase which is not
required for transport (Barnett and von Kalm; unpublished). Results from these experiments are
shown in figure 5. A 1-way ANOVA revealed no statistically significant differences between the
genotypes tested. No survivors were observed in OreR, CG6230 and CG32000 B exon mutants
grown in 30 mM norspermidine. A few animals (5/200) survived after RNAi knockdown of
CG32000. These data suggest that norspermidine uses an alternative transport system from

Percentage of Surviving Larvae

CG32000 to gain entry to cells.

140
120
100
80
60
40
20
0
Ore R
0 mM
Nor

Ore R CG6230 CG6230 CG32000CG32000CG32000CG32000
B exon B exon RNAi
RNAi
30 mM
Nor

0 mM 30 mM 0 mM 30 mM
Nor
Nor
Nor
Nor
Genotype and Concentration

0 mM
Nor

30 mM
Nor

Figure 5:RNAi knockdown and mutation of CG32000 does not block uptake of norspermidine. Percent survival of
OreR, CG6230 RNAi, CG32000 B exon mutants, and CG32000 RNAi larvae in 0 and 30 mM norspermidine. All
experiments were performed in triplicate and error bars reflect standard error. Data was normalized with the 0 mM
OreR control set as 100%.

To ensure that the B exon and RNAi CG32000 strains were genetically intact I asked if these
strains were unable to transport polyamines in the presence of a lethal concentration of DFMO.
14

DFMO blocks polyamine synthesis and forces larvae to rely on transport of exogenous polyamines
to survive. If the larvae have a functional transport system, the presence of polyamines (putrescine
and spermidine) will provide rescue. Otherwise, larvae will not survive. Data for the B exon mutant
are shown in figure 6 (see Methods for experimental details). Lethality caused by 5 mM DFMO
could not be rescued by exogenous putrescine or spermidine indicating that the PTS was nonfunctional in these animals. Similar results were observed for RNAi against CG32000 (data not
shown).

140

Percent Survival, normalized to control

*
120
100
80
60
40

20

***

***

0
H2O

DFMO

Put

Put+DFMO

***
Spd

Spd+DFMO

Treatment and vial

Figure 6:Testing of B exon stocks. Exogeneous polyamines fail to rescue B exon CG32000 larvae grown in a lethal
concentration of DFMO. A 1-way ANOVA revealed that changes in survival between the control and polyamine +
DFMO conditions is statistically significant (P<0.001). All experiments were performed in triplicate and error bars
reflect standard error. Data were normalized with the 0 mM OreR control set as 100%.
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Developmental Profiles of OreR and B exon CG32000 mutants in the presence of norspermidine.

The surprising finding that norspermidine did not utilize the PTS involving CG32000 led me to
ask if animals exhibited abnormal developmental profiles. If animals grown on norspermidine
were severely developmentally delayed, then the absence of survivors for B exon and RNAi
CG32000 in Figure 5 might reflect this rather than the use of an alternative transport system by
norspermidine. Developmental data for OreR and the B exon mutant are shown in Figures 7 and 8
respectively.
For OreR, animals grown on all concentrations of norspermidine except 30 mM, which was lethal,
began to emerge within 2 days of control 0 mM norspermidine animals. In addition, peak eclosion
numbers (the point at which no more flies emerged) occurred at approximately the same time for
all concentrations of norspermidine tested. For B exon mutants concentrations above 20 mM were
lethal, however initial eclosion and peak eclosion times were similar for all concentrations tested.
Thus, severe developmental delay does not seem to be a viable alternative explanation for my
observations.
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90
80

% Adults observed

70
0 mM Norspermidine

60

5 mM

50

10 mM
40

15 mM

30

20 mM
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10

30 mM

0
0
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2

3

4

5

6

7

8

9

10

Time (days)

Figure 7:Developmental profile of OreR during norspermidine exposure. Cumulative average percent of adult OreR
flies observed after each day for a range of norspermidine concentrations. The first day that adult flies were
observed in the control is counted as Day 1.
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% Adults observed

60
50
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10 mM
30
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Figure 8:Developmental profile of CG32000 B exon mutant flies during norspermidine exposure. Cumulative
average percent of adult CG32000 B exon mutant flies observed after each day for a range of norspermidine
concentrations. The first day that adult flies were observed in the control is counted as Day 1.
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DISCUSSION

The initial goal of this project was to investigate the feasibility of using norspermidine to screen
for genes involved in polyamine transport. A major advantage of this approach over the current
DFMO based approach used in the laboratory is that animals can only survive if they are unable
to transport polyamines. Thus, batches of genes could be tested simultaneously and if a few
survivors are observed the batch could be broken down to individual genes for further testing. In
contrast in the DFMO screen animals must transport to survive and genes are tested individually
in this survival based assay. Unfortunately, my data suggest that a norspermidine based screen will
not be feasible in Drosophila.
There were three major findings from my work. First, the lethal concentration of norspermidine in
Drosophila (30 mM) is ten times higher than the lethal concentration in C. elegans (Heinick et al
2010). Second, my data show that norspermidine gains entry to cells via an alternative mechanism
to that used by CG32000, a gene required for polyamine transport. Third, I have shown that my
data cannot be explained by severe developmental delay associated with uptake of norspermidine.
The lethal concentration of norspermidine for wild-type C. elegans was observed to be 3 mM
(Heinick, 2010). Drosophila required ten times this amount. This may indicate an increased ability
to export or metabolize norspermidine in Drosophila, thereby mitigating its toxicity. Alternatively,
a separate transport system with a decreased affinity for norspermidine (compared to C. elegans)
may also explain these results. Support for multiple transport pathways in Drosophila comes from
recent work using a chemical approach showing that polyamine transport inhibitors differ in the
relative abilities to block the uptake of the native polyamines (Wang et al., 2017). This study also
19

showed that a cocktail of polyamine transport inhibitors is more effective than individual inhibitors
alone to blocking transport. One limitation of this study is that the norspermidine was not tested
on C. elegans to confirm a similar level of toxicity as observed by Heinick et al.
While mutations disrupting the C. elegans gene CATP-5 enabled worms to survive even in 5
mM norspermidine, flies with a nonfunctional CG32000 gene (the orthologue of CATP-5) showed
no decrease in sensitivity to norspermidine compared to wild-type flies, either in terms of increased
survival or decreased developmental delay. Exposing the same strain of flies to DFMO and
polyamines confirmed that the flies were unable to transport native polyamines, as the presence of
exogenous polyamines was unable to provide rescue from DFMO. Knocking down CG32000
using RNAi yielded comparable results. One explanation may be that at sufficiently high
concentrations, norspermidine uptake occurs via a secondary transport system. To further address
this question it will be important to test the ability of the native polyamines to competitively inhibit
norspermidine uptake. If an alternative transport system is used the native polyamines may not be
able to competitively inhibit norspermidine transport.
Finally, while the lethal concentration of norspermidine is 30mM for OreR, it is 20mM for the B
exon mutant of CG32000 (cf. Figures 7 and 8). Overall viability is compromised in the B exon
mutant (Barnett and von Kalm unpublished) presumably due to inability to transport polyamines.
This coupled with exposure to norspermidine may increase the sensitivity to this compound.
Future studies should be directed at better understanding the mechanism of norspermidine uptake
and how it relates to polyamine transport in general. If, as recent evidence suggests (Wang et al,
2017 and this study), there are multiple transport systems, it will be important to understand them
20

to facilitate the design of effective polyamine transport inhibitors to be used in conjunction with
DFMO in cancer therapy.

21

REFERENCES
Assaraf, Y. G., Golenser, J., Spira, D. T., & Bachrach, U. (1984). Polyamine levels and the activity
of their biosynthetic enzymes in human erythrocytes infected with the malarial parasite,
Plasmodium falciparum. Biochemical Journal, 222:3:815–819.

Bachrach, U., Brem, S., Wertman, S.B., Schnur, L.F., Greenblatt, C.L. (1979). Leishmania spp.:
Cellular levels and synthesis of polyamines during growth cycles. Experimental
Parasitology, 48:457-463

Belting, M.; Mani, K.; Jonsson, M.; Cheng, F.; Sandgren, S.; Jonsson, S.; Ding, K.; Delcros, J.G.; Fransson, L.A. (2003). Glypican-1 is a vehicle for polyamine uptake in mammalian
cells: A pivotal role for nitrosothiol-derived nitric oxide. J. Biol. Chem. 278:47181–47189.

Bern, C., Kjos, S., Yabsley, M. J., & Montgomery, S. P. (2011). Trypanosoma cruzi and Chagas’
Disease in the United States. Clinical Microbiology Reviews, 24:4:655–681.
http://doi.org/10.1128/CMR.00005-11

Caldwell, K. A., Shu, Y., Roberts, N. B., Caldwell, G. A., & O’Donnell, J. M. (2013). Invertebrate
Models

of

Dystonia.

Current

http://doi.org/10.2174/157015913804999504

22

Neuropharmacology,

11:1:16–29.

Chatel M, Darcel F, Quemener V, Hercouet H, Moulinoux JP. (1987). Red blood cell polyamines
as biochemical markers of supratentorial malignant gliomas. Anticancer Res., 7:33–38.

Childs, A. C., Mehta, D. J., Gerner, E. W. (2003). Polyamine-dependent gene expression. Cell.
Mol. Life Sci. 60,1394-1406

Desjeux, P. (2001). The increase in risk factors for leishmaniasis worldwide. Transactions of The
Royal

Society

of

Tropical

Medicine

and

Hygiene,

95:3:1:239–243,

https://doi.org/10.1016/S0035-9203(01)90223-8

Duffy, J. B. (2002), GAL4 system in Drosophila: A fly geneticist's swiss army knife. Genesis, 34:
1–15. doi:10.1002/gene.10150

Durie BG, Salmon SE, Russell DH. Polyamines as markers of response and disease activity in
cancer chemotherapy. Cancer Res. 1977, 37: 214-221.

Eisenberg T, et al. (2009). Induction of autophagy by spermidine promotes longevity. Nat. Cell
Biol, 11:1305–1314. doi: 10.1038/ncb1975.

Hochman J, Katz A, Bachrach U. (1978), Polyamines and protein kinase II. Effect of polyamines
on cyclic AMP--dependent protein kinase from rat liver. Life Sci. 22:1481–1484. doi:
10.1016/0024-3205(78)90002-4.
23

Heinick, A., Urban, K., Roth, S., Spies, D., Nunes, F., Phanstiel, O., … Lüersen, K. (2010).
Caenorhabditis elegans P5B-type ATPase CATP-5 operates in polyamine transport and is
crucial for norspermidine-mediated suppression of RNA interference. The FASEB Journal,
24(1), 206–217. http://doi.org/10.1096/fj.09-135889

Hiasa,M.;Miyaji, T.; Haruna, Y.; Takeuchi, T.; Harada, Y.;Moriyama, S.; Yamamoto,A.;
Omote,H.;Moriyama, Y. (2014). Identification of a mammalian vesicular polyamine
transporter. Sci. Rep. 4:6836.

Hussain, T., Tan, B., Ren, W. et al. (2017). Polyamines: therapeutic perspectives in oxidative stress
and inflammatory diseases. Amino Acids, 49:1457. https://doi.org/10.1007/s00726-0172447-9

Kashiwagi, K.; Endo, H.; Kobayashi, H.; Takio, K.; Igarashi, K. (1995). Spermidine-preferential
uptake system in Escherichia coli. ATP hydrolysis by PotA protein and its association with
membrane. J. Biol. Chem. 270:25377-25382.

Kubota S, Okada M, Yoshimoto M, Murata N, Yamasaki Z, Wada T, Imahori K, Ohsawa N,
Takaku F. (1985). Urinary polyamines as a tumor marker. Cancer Detect Prev.8:189–192.

24

Loser C, Folsch UR, Paprotny C, Creutzfeldt W. (1990). Polyamines in colorectal cancer.
Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients
with

colorectal

cancer.

Cancer,

65:958–966.

doi:

10.1002/1097-

0142(19900215)65:4<958::AID-CNCR2820650423>3.0.CO;2-Z.

Luk, G. D., & Casero, R. A. (1987). Polyamines in normal and cancer cells. Advances in Enzyme
Regulation.

Retrieved

November

15,

2016,

from

http://www.sciencedirect.com/science/article/pii/0065257187900070

Machius,M.; Brautigam, C.A.; Tomchick, D.R.;Ward, P.; Otwinowski, Z.; Blevins, J.S.; Deka,
R.K.; Norgard,M.V. (2007). Structural and biochemical basis for polyamine binding to the
Tp0655 lipoprotein of Treponema pallidum: Putative role for Tp0655 (TpPotD) as a
polyamine receptor. J.Mol. Biol. 373:681–694.

Marie-Pierre, H.; Buddy, U. (2005). Identification and characterization of polyamine permease
from the protozoan parasite Leishmania major. J. Biol. Chem. 208:15188–15194.

Minois, N., Carmona-Gutierrez, D., & Madeo, F. (2011). Polyamines in aging and disease. Aging
(Albany NY), 3:8:716–732.

Mohammed, A., Janakiram, N. B., Madka, V., Ritchie, R. L., Brewer, M., Biddick, L., … Rao, C.
V. (2014). Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating
25

Ornithine Decarboxylase Signaling. Cancer Prevention Research (Philadelphia, Pa.),
7(12), 1198–1209. http://doi.org/10.1158/1940-6207.CAPR-14-0176

Panagiotidis CA, Artandi S, Calame K, Silverstein SJ. (1995). Polyamines alter sequence-specific
DNA-protein

interactions.

Nucleic

Acids

Res,

23:1800–1809.

doi:

10.1093/nar/23.10.1800.

Pegg, A. E. (2009). Mammalian Polyamine Metabolism and Function. IUBMB Life, 61(9), 880–
894. http://doi.org/10.1002/iub.230

Reigada, C., Valera-Vera, E., Sayé, M., Errasti, A., Avila, C., and Miranda, M. (2017).
Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid
Transporters in Trypanosoma cruzi. PLoS Neglected Tropical Diseases, 11:3:5472.
https://doi.org/10.1371/journal.pntd.0005472

Rhee, H. J., Kim, E.-J., & Lee, J. K. (2007). Physiological polyamines: simple primordial stress
molecules. Journal

of

Cellular

and

Molecular

Medicine, 11:4:685–703.

http://doi.org/10.1111/j.1582-4934.2007.00077.x

Russell D.H. Clinical relevance of polyamines. (1983). Crit. Rev. Clin. Lab. Sci, 18:261–311. doi:
10.3109/10408368209085073.

26

Sarathy, J.P., Lee, E., Dartois, V. (2013). Polyamines Inhibit Porin-Mediated Fluoroquinolone
Uptake

in

Mycobacteria.

PLoS

ONE8(6):

e65806.

https://doi.org/10.1371/journal.pone.0065806

Siegel, R.L., Miller, K.D. and Jemal, A. (2016), Cancer statistics, 2016. CA: A Cancer Journal for
Clinicians, 66: 7–30. doi:10.3322/caac.21332

Soda, K. (2011). The mechanisms by which polyamines accelerate tumor spread. Journal of
Experimental & Clinical Cancer Research : CR, 30:1:95. http://doi.org/10.1186/17569966-30-95

Soulet, D.; Gagnon, B.; Rivest, S.; Audette, M.; Poulin, R. (2004). A fluorescent probe of
polyamine transport accumulates into intracellular acidic vesicles via a two-step
mechanism. J. Biol. Chem. 279:49355–49366.

Tabib, A., Bachrach, U. (1994). Activation of the proto-oncogene c-myc and c-fos by c-ras:
involvement of polyamines. Biochem Biophys Res Commun, 202:720–727. doi:
10.1006/bbrc.1994.1990.

Tsen, C., Iltis, M., Kaur, N., Bayer, C., Delcros, J., von Kalm, L., and Phanstiel, O. (2008). A
Drosophila Model To Identify Polyamine−Drug Conjugates That Target the Polyamine

27

Transporter in an Intact Epithelium. Journal of Medicinal Chemistry, 51 (2), 324-330.
DOI: 10.1021/jm701198s

Uehara, N., Shirakawa,. S, Uchino, H., Saeki, Y. (1980). Elevated contents of spermidine and
spermine in the erythrocytes of cancer patients. Cancer. 45:108–111. doi: 10.1002/10970142(19800101)45:1<108::AID-CNCR2820450120>3.0.CO;2-W.

Uemura, T.; Kashiwagi, K.; Igarashi, K. (2005). Uptake of putrescine and spermidine byGap1p on
the plasma membrane in Saccharomyces cerevisias. Biochem. Biophys. Res. Commun.
328:1028–1033.

Uemura, T.; Yerushalmi, H.F.; Tsaprailis, G.; Stringer, D.E.; Pastorian, K.E.; Hawel, L.; Byus,
C.V.; Gerner, E.W. (2008). Identification and characterization of a diamine exporter in
colon epithelial cells. J. Biol. Chem. 283:26428–26435.

Wang, M., Phanstiel, O., von Kalm, L. (2017). Evaluation of Polyamine Transport Inhibitors in a
Drosophila Epithelial Model Suggests the Existence of Multiple Transport Systems.
Medical Sciences. 5:4:27.

28

